References
- FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365E359E38625220842
- Global Burden of Disease Cancer CollaborationFitzmauriceCDickerDPainAThe global burden of cancer 2013JAMA Oncol20151450552726181261
- JungKWWonYJKongHJOhCMLeeDHLeeJSCancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011Cancer Res Treat201446210912324851102
- LiXCaiHWangCGuoCHeZKeYEconomic burden of gastrointestinal cancer under the protection of the new rural cooperative medical scheme in a region of rural China with high incidence of oesophageal cancer: cross-sectional surveyTrop Med Int Health201621790791627125226
- FuchsHHolscherAHLeersJLong-term quality of life after surgery for adenocarcinoma of the esophagogastric junction: extended gastrectomy or transthoracic esophagectomy?Gastric Cancer201619131231725627475
- TorranceGWUtility approach to measuring health-related quality of lifeJ Chronic Dis19874065936033298297
- TorranceGWMeasurement of health state utilities for economic appraisalJ Health Econ19865113010311607
- De WitGABusschbachJJDe CharroFTSensitivity and perspective in the valuation of health status: whose values count?Health Econ20009210912610721013
- ChapmanBPFranksPDubersteinPRJerantADifferences between individual and societal health state valuations: any link with personality?Med Care200947890290719543121
- RussellLBGoldMRSiegelJEDanielsNWeinsteinMCThe role of cost-effectiveness analysis in health and medicine. Panel on Cost- Effectiveness in Health and MedicineJAMA199627614117211778827972
- CarterGCKingDTHessLMHealth state utility values associated with advanced gastric, oesophageal, or gastro-oesophageal junction adenocarcinoma: a systematic reviewJ Med Econ2015181195496626212479
- ShanBShanLMorrisDGolaniSSaxenaASystematic review on quality of life outcomes after gastrectomy for gastric carcinomaJ Gastrointest Oncol20156554456026487949
- AreiaMAlvesSBritoDHealth-related quality of life and utilities in gastric premalignant conditions and malignant lesions: a multicentre study in a high prevalence countryJ Gastrointestin Liver Dis201423437137825531994
- Cancer.go.kr [homepage on the Internet]GoyangNational Cancer Information Center [updated March 15, 2018; cited May 2, 2014]. Available from: https://www.cancer.go.kr/lay1/program/S1T211C213/cancer/view.do?cancer_seq=4661Accessed March 2, 2018
- Korean Academy of Medical SciencesKorean Clinical Practice Guideline for Gastric CancerSeoulDongA-Sa2012
- van OschSMStiggelboutAMThe construction of standard gamble utilitiesHealth Econ2008171314017410521
- FerreiraLNFerreiraPLPereiraLNOppeMThe valuation of the EQ-5D in PortugalQual Life Res201423241342323748906
- LeeJYOckMJoMWEstimating utility weights and quality-adjusted life year loss for colorectal cancer-related health states in KoreaSci Rep201771557128717246
- BaeJMKimSKimYWHealth-related quality of life among disease-free stomach cancer survivors in KoreaQual Life Res200615101587159617036253
- MalatyHMKimJGKimSDGrahamDYPrevalence of Helicobacter pylori infection in Korean children: inverse relation to socioeconomic status despite a uniformly high prevalence in adultsAm J Epidemiol199614332572628561159
- OhDYChoiKSShinHRBangYJPublic awareness of gastric cancer risk factors and disease screening in a high risk region: a population-based studyCancer Res Treat2009412596619707502
- ZhouHJSoJBYongWPValidation of the functional assessment of cancer therapy-gastric module for the Chinese populationHealth Qual Life Outcomes20121014523194009
- HisashigeASasakoMNakajimaTCost-effectiveness of adjuvant chemotherapy for curatively resected gastric cancer with S-1BMC Cancer20131344324079752
- KontodimopoulosNAletrasVHPaliourasDNiakasDMapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instrumentsValue Health20091281151115719558372
- CurranDPozzoCZaluskiJQuality of life of palliative chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction treated with irinotecan combined with 5-fluorouracil and folinic acid: results of a randomised phase III trialQual Life Res200918785386119568958
- WangPLuoNTaiESThumbooJThe EQ-5D-5L is more discriminative than the EQ-5D-3L in patients with diabetes in SingaporeValue Health Reg Issues20169576227881260
- MarraCAWoolcottJCKopecJAA comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritisSoc Sci Med20056071571158215652688
- ProsserLAPayneKRusinakDShiPUyekiTMessonnierMValuing health across the lifespan: health state preferences for seasonal influenza illnesses in patients of different agesValue Health201114113514321211495
- LeeGMSalomonJALeBaronCWLieuTAHealth-state valuations for pertussis: methods for valuing short-term health statesHealth Qual Life Outcomes200531715780145
- CoonsSJRaoSKeiningerDLHaysRDA comparative review of generic quality-of-life instrumentsPharmacoeconomics200017133510747763
- JohnsonJALuoNShawJWKindPCoonsSJValuations of EQ-5D health states: are the United States and United Kingdom different?Med Care200543322122815725978
- ChangHSParkECChungWComparing endoscopy and upper gastrointestinal X-ray for gastric cancer screening in South Korea: a cost-utility analysisAsian Pac J Cancer Prev20121362721272822938448
- WuBLiTCaiJXuYZhaoGCost-effectiveness analysis of adjuvant chemotherapies in patients presenting with gastric cancer after D2 gastrectomyBMC Cancer20141498425526802
- LamSWWaiMLauJEMcNamaraMEarlMUdehBCost-effectiveness analysis of second-line chemotherapy agents for advanced gastric cancerPharmacotherapy20173719410327870079
- RahmanRAsombangAWIbdahJACharacteristics of gastric cancer in AsiaWorld J Gastroenterol201420164483449024782601